Detalles de la búsqueda
1.
Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer.
J Natl Compr Canc Netw
; 21(10): 1050-1057.e13, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856197
2.
First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies.
Invest New Drugs
; 40(3): 586-595, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113285
3.
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
Radiology
; 298(1): 60-70, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33201788
4.
Enhancing Cancer care of rural dwellers through telehealth and engagement (ENCORE): protocol to evaluate effectiveness of a multi-level telehealth-based intervention to improve rural cancer care delivery.
BMC Cancer
; 21(1): 1262, 2021 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814868
5.
IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results.
BMC Cancer
; 21(1): 1099, 2021 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34645413
6.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
7.
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 37(2): 315-322, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30191522
8.
Translating preclinical MRI methods to clinical oncology.
J Magn Reson Imaging
; 50(5): 1377-1392, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30925001
9.
First-in-human phase I dose escalation study of MK-8033 in patients with advanced solid tumors.
Invest New Drugs
; 36(5): 860-868, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29376210
10.
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trial.
Invest New Drugs
; 36(3): 442-450, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28990119
11.
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer.
Invest New Drugs
; 36(6): 1158, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30334109
12.
Phase II study of the Multikinase inhibitor of angiogenesis, Linifanib, in patients with metastatic and refractory colorectal cancer expressing mutated KRAS.
Invest New Drugs
; 35(4): 491-498, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28353122
13.
A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers.
Invest New Drugs
; 35(1): 95-104, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853997
14.
DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer.
NMR Biomed
; 30(11)2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28915312
15.
Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary results.
Breast Cancer Res Treat
; 155(2): 273-84, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26791520
16.
Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.
NMR Biomed
; 28(10): 1345-56, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26332194
17.
Sequence design and evaluation of the reproducibility of water-selective diffusion-weighted imaging of the breast at 3 T.
NMR Biomed
; 27(9): 1030-6, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24986756
18.
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors.
JTO Clin Res Rep
; 5(2): 100619, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38328473
19.
Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer.
Magn Reson Med
; 69(6): 1721-34, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22847762
20.
Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.
Magn Reson Med
; 70(1): 216-24, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22907893